Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Thomas Jefferson University
Center for International Blood and Marrow Transplant Research
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Thomas Jefferson University
City of Hope Medical Center
University Hospital, Toulouse
Alliance for Clinical Trials in Oncology
Medical College of Wisconsin
University of Washington
National Cancer Institute (NCI)
Stanford University
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Regimmune Corporation
Children's Oncology Group
Children's Hospital of Philadelphia
Abramson Cancer Center at Penn Medicine
Masonic Cancer Center, University of Minnesota
European Myeloma Network B.V.
Massachusetts General Hospital
Massachusetts General Hospital
Dana-Farber Cancer Institute
Massachusetts General Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
Fate Therapeutics
University of Utah
National Cancer Institute (NCI)
University of Rochester
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center